Lycera's Series B Round

Lycera raised a round of funding on June 22, 2015.

Lycera is a biopharmaceutical company pioneering approaches to the discovery and development of oral medicines for treating autoimmune diseases. The company is targeting pathways to develop new classe…

Articles about Lycera's Series B Round: